Drugs / HLA matched stem cell
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT02461121 Comparator | May 2004 → May 2013 | acute myeloid leukemia | The Affiliated Hospital of the Chinese Academy of Military Medical Sciences | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HLA matched stem cell | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02461121 ↗ |
| Modality | Cell therapy | “HLA matched donor G-CSF mobilized peripheral stem cell infused after the conditioning reginmen” NCT02461121 ↗ |
| Route | Other | “HLA matched donor G-CSF mobilized peripheral stem cell infused after the conditioning reginmen” NCT02461121 ↗ |